Boron Neutron Capture Therapy of Uveal Melanoma

BPA Biodistribution on Human Cells Xenografted to Nude Mice
  • J. P. Pignol
  • P. Chauvel
  • J. C. Abbe


Ocular melanomas are rare tumors1 (annual incidence of 0.7/100 000 in the USA), which occur in adults close to 60 years old. They arise in the choroïd (Fig.1), which is the ocular vascular tunique, mostly in the eye fundus or, to a lesser extent, in the ciliary body2.


Nude Mouse Neutron Capture Linear Energy Transfer Uveal Melanoma Boron Neutron Capture Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L.E. Zimmerman, Malignant melanoma of the uveal tract, in “Ophtalmie Pathology”, W.H. Spencer, ed.. J.B. Lippincott Co., Philadelphia, 1986, pp. 2072–2139.Google Scholar
  2. 2.
    J.A. Sahel, J.D. Earle, D.M. Albert, Intraocular melanomas, in “Cancer, Principles and Practice of Oncology, 4th edition,” V.T. De Vita Jr., S. Hellman, S.A. Rosenberg, J.B. Lippincott Co., Philadelphia, 1993, pp. 1662–1678.Google Scholar
  3. 3.
    I.W. Mc Lean, W.D. Foster, L.E. Zimmerman, Uveal melanoma: Location, size, cell type and enucleation as risk factors in metastasis. Hum. Pathol. 13: 123–132, 1981.CrossRefGoogle Scholar
  4. 4.
    E.S. Gragoudas, K.M. Egan, J.M. Seddon, R.J. Glynn, S.M. Walsh, S.M. FinnJ.E. Munzenrider, M.D. Spar, Survival of patients with metastases from uveal melanoma. Ophtalmologs’, 3: 383–389, 1991.Google Scholar
  5. 5.
    R.G. Fairchild, New radiotherapeutic techniques in nuclear ophtalmology. Semin. Nuc/. Med.. 14: 35–45, 1984.CrossRefGoogle Scholar
  6. 6.
    J.P. Pignol, L. Meyer, A. Methlin, J.P. Wagner, J.C. Abbe, J. Sahel, Radiothérapie des mélanomes oculaires: Bases physiques et radiobiologiques, techniques actuelles et perspectives d’avenir. Bull. Cane., 81: 127–142, 1994.Google Scholar
  7. 7.
    S. Packer, J. Coderre, S. Saraf, R.G. Fairchild, J. Hansrote, H. Perry, Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine. Invest. Ophtalmol. Ps. Sci., 33: 395–403, 1992.Google Scholar
  8. 8.
    J.A. Coderre, J.D. Glass, R.G. Fairchild, U. Roy, S. Cohen, I. Fand, Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. Cancer Res., 47: 6377–6383, 1987.PubMedGoogle Scholar
  9. 9.
    D. Gabel, H. Holstein, B. Larsson, L. Gille, G. Ericson, D. Sacker, P. Som, R.G. Fairchild, Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron-containing compounds. Cancer Res., 47: 5451–5454, 1987.PubMedGoogle Scholar
  10. 10.
    J.P. Pignol, J.C. Abbe, O. Lefebvre, G. Stampfler, A. Methlin, J. Sahel, Thérapie par capture de neutrons des mélanomes oculaires: approche de la dosimétrie et de la microdosimétrie liée à la distribution tissulaire et cellulaire de la 10B-boronophénylalanine. C. R. Acad. Sci., 317: 543–548, 1994.Google Scholar
  11. 11.
    J.A. Coderre, J.D. Glass, R.G. Fairchild, P.L. Micca, J. Kalef-Ezra, Boronophenylalanine for neutron capture therapy of melanoma. Strahl. Onkol., 165: 215–217, 1989.Google Scholar
  12. 12.
    J.A. Coderre, J.D. Glass, R.G. Fairchild, P.L. Micca, I. Fand, D.D. Joel, Selective delivery of boron by the melanin precursor analog p-boronophenylalanine to tumors other than melanoma. Cancer Res., 50: 138–141, 1990.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • J. P. Pignol
    • 1
  • P. Chauvel
    • 1
  • J. C. Abbe
    • 2
  1. 1.Cyclotron Biomedical — Centre Antoine LacassagneNiceFrance
  2. 2.Laboratoire SUBATECHEcole des MinesNantes Cedex 04France

Personalised recommendations